BRIEF published on 04/11/2025 at 20:05, 11 months 12 days ago Oxurion Publie son Rapport Annuel 2024 et Convoque son Assemblée Générale Déclarations Prospectives Rapport Annuel 2024 Oxurion NV Thérapies Ophtalmologiques Assemblées Actionnaires
BRIEF published on 04/11/2025 at 20:05, 11 months 12 days ago Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE published on 04/11/2025 at 20:05, 11 months 12 days ago Publication Annual Report - Annual Shareholders' Meeting Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
PRESS RELEASE published on 04/11/2025 at 20:00, 11 months 12 days ago Publicatie jaarverslag - Jaarlijkse Algemene Vergadering Oxurion NV publice son rapport annuel 2024, convoque son assemblée annuelle d'actionnaires et se concentre sur les thérapies ophtalmologiques Rapport Annuel 2024 Oxurion NV Assemblée Annuelle Thérapies Ophtalmologiques Biofarmaceutique
BRIEF published on 04/04/2025 at 14:05, 11 months 19 days ago Report de l'Assemblée Générale d'Oxurion Assemblée Générale Biopharmaceutique Report Oxurion Thérapies Ophtalmologiques
BRIEF published on 04/04/2025 at 14:05, 11 months 19 days ago Oxurion General Meeting Postponed General Meeting Biopharmaceuticals Report Ophthalmic Therapies Oxurion
PRESS RELEASE published on 04/04/2025 at 14:00, 11 months 19 days ago Uitstel Gewone Algemene Vergadering Oxurion NV annonce le report de son Assemblée Générale des Actionnaires au 13 mai 2025 en raison de l'indisponibilité de ses états financiers Assemblée Générale États Financiers Report Risques Oxurion NV
PRESS RELEASE published on 04/04/2025 at 14:00, 11 months 19 days ago Postponement Annual Shareholders Meeting Oxurion NV postponed its Annual Shareholders Meeting to May 13, 2025, due to pending annual accounts. The biopharmaceutical company, focused on ophthalmic therapies, is based in Leuven, Belgium Biopharmaceutical Annual Shareholders Meeting Postponed Ophthalmic Therapies Oxurion NV
BRIEF published on 04/02/2025 at 18:05, 11 months 21 days ago Oxurion reçoit une notification de transparence de Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Biopharmacie
BRIEF published on 04/02/2025 at 18:05, 11 months 21 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
Published on 03/23/2026 at 14:05, 6 hours 38 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 6 hours 43 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 7 hours 38 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 8 hours 11 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 8 hours 13 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 19:30, 1 hour 12 minutes ago Habitat for Humanity launches Let's Open the Door campaign to drive awareness of global housing need
Published on 03/23/2026 at 19:00, 1 hour 43 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 16 MARS 2026 au 20 MARS 2026
Published on 03/23/2026 at 18:15, 2 hours 27 minutes ago ISX Financial EU Plc Announces Corporate Name Change to Xryma Plc
Published on 03/23/2026 at 19:08, 1 hour 34 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 1 hour 34 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 2 hours 5 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 2 hours 57 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 2 hours 57 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
